Information on Directors’ Dealings and Shareholding

According to section 15a of the German Securities Trading Act (Wertpapierhandelsgesetz, WpHG), members of the Management and Supervisory Boards or other employees in management positions are required to inform the Company when buying or selling shares in Fresenius Medical Care and related financial instruments if the volume exceeds €5,000 within a single year. During fiscal year 2010, we received a total of seven disclosures according to section 15a of the German Securities Trading Act, which we published on our website at www.fmc-ag.com in the section Investor Relations/Corporate Governance/Directors’ Dealings/Single Dealings in accordance with applicable regulations and which are in addition set out in the “Annual Document” under www.fmc-ag.com in the section Investor Relations/Corporate Governance/Article 10 of the Securities Prospectus Act (WpPG) 2010.